| Date Filed | Type | Description |
| 12/08/2021 |
4
| Zarrabian Saiid (Head of Strategic Partnerships) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Bought 11,891 shares
@ $0.5902, valued at
$7k
Bought 38,109 shares
@ $0.6376, valued at
$24.3k
|
|
| 09/17/2020 |
4
| Zarrabian Saiid (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 2,715,004 options to buy
@ $1.7, valued at
$4.6M
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2018 |
4
| Zarrabian Saiid (President and CEO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Granted 836,465 options to buy
@ $0.9825, valued at
$821.8k
|
|
| 11/16/2017 |
4
| Zarrabian Saiid (Interim CEO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Bought 55,000 shares
@ $0.82, valued at
$45.1k
Bought 5,900 shares
@ $0.84, valued at
$5k
|
|
| 11/07/2017 |
4
| Zarrabian Saiid (Interim CEO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Granted 120,000 options to buy
@ $0.87, valued at
$104.4k
|
|
| 07/11/2017 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Granted 36,000 options to buy
@ $2.11, valued at
$76k
Granted 200,000 rights
@ $0 |
|
| 07/11/2017 |
3
| Zarrabian Saiid (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc. |
| 05/15/2015 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Bought 307 shares
@ $19.5, valued at
$6k
|
|
| 02/25/2015 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 10,000 options to buy
@ $19.69, valued at
$196.9k
|
|
| 08/05/2014 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Bought 381 shares
@ $9.53, valued at
$3.6k
|
|
| 04/07/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/26/2013 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 900,000 options to buy
@ $0.12, valued at
$108k
|
|
| 10/11/2013 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 10,360,892 shares
@ $0
Granted 3,981,146 shares
@ $0
Disposed/sold 18,907,498 options to buy
@ $0.06, valued at
$1.1M
|
|
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/18/2012 |
4/A
| Zarrabian Saiid (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 18,907,498 options to buy
@ $0.06, valued at
$1.1M
|
|
| 04/12/2012 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 1,180,442 shares
@ $0
Granted 10,360,892 shares
@ $0
Granted 11,541,334 options to buy
@ $0.06, valued at
$692.5k
|
|
| 01/30/2012 |
3
| Zarrabian Saiid (Director) has filed a Form 3 on LA JOLLA PHARMACEUTICAL CO |
| 09/22/2010 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on PENWEST PHARMACEUTICALS CO|
Txns:
| Unknown transaction of 20,000 shares
@ $0 |
|
| 07/02/2010 |
4
| Zarrabian Saiid (Director) has filed a Form 4 on PENWEST PHARMACEUTICALS CO|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 07/02/2010 |
3
| Zarrabian Saiid (Director) has filed a Form 3 on PENWEST PHARMACEUTICALS CO |